FDA grants fast track designation to Wockhardt's novel antibiotic WCK 6777
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
The acquisition will strengthen the overall company’s position as leading global CRO services partner
Poor oral health (periodontal disease) impacts nearly 51% of Indians
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
This office will be the central hub for all operations related to companies ethical pharmaceutical business
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
KEYTRUDA is the first and only immunotherapy-based regimen to show a statistically significant and clinically meaningful improvement in overall survival
The publication serves as a foundational tool for identifying gaps and addressing needs in various areas, including rural, urban, and tribal regions
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
Subscribe To Our Newsletter & Stay Updated